EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

High-level expression of full-length human CYP2E1 in Escherichia coli: Comparison of full-length human CYP2E1 to truncated counterpart shows enhanced association with redox partners

Yudong Sun, Praveen Amunugama, Yoichi Osawa, Haoming Zhang

Drug Metabolism and Disposition · 2026-07 · 54 (7) · 100344

DOI: 10.1016/j.dmd.2026.100344 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Drug Metabolism and Disposition, 2026-07. Verfasst von Yudong Sun und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, The University of Michigan Medical School, Ann Arbor, Michigan. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP2E1, Escherichia coli. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, University of Michigan, National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Few liver microsomal cytochromes P450 (P450s), especially human P450s, are recombinantly expressed in bacteria as full-length proteins. Lack of the N-terminal membrane anchor hinders studies of the interactions of microsomal P450s with redox partners. Herein, we describe the successful expression of full-length human CYP2E1, referred to as hCYP2E1FLAL, in bacteria to give a yield of ∼704 nmol/L culture. This high-level expression was achieved due to the codon optimization strategy employed to reduce free energy for translation and growth temperature. The expressed hCYP2E1FLAL was purified with a single affinity column and contained no P420, the inactive form of P450. Compared with N-terminal truncated human CYP2E1 (hCYP2E1dH), hCYP2E1FLAL exhibits elevated enzyme activity toward prototypic substrates, chlorzoxazone and p-nitrophenol, with ∼2-fold increase in kcat in the absence of cytochrome-b5 (cyt b5). The elevated enzyme activity is more pronounced in the presence of cyt b5, with a 4.3-fold increase for chlorzoxazone and a 2.5-fold increase for p-nitrophenol. Moreover, hCYP2E1FLAL binds NADPH-cytochrome P450 oxidoreductase (POR) more tightly with an apparent KM of 0.36 ± 0.026 μM, compared to 1.2 ± 0.13 μM for truncated hCYP2E1dH. Interestingly, the presence of cyt b5 further decreased the KM of POR to 0.13 ± 0.014 μM for hCYP2E1FLAL as opposed to 0.40 ± 0.041 μM for hCYP2E1dH, suggesting that cyt b5 promotes the interactions of CYP2E1 with POR. Taken together, these results suggest that the N-terminal transmembrane anchor enhances hCYP2E1-catalyzed reactions, likely by favorable interactions with POR and cyt b5 to form active complexes with redox partners, and that the full-length enzyme is the appropriate form for further redox partner interaction studies in membrane systems. SIGNIFICANCE STATEMENT: In vitro drug metabolism by CYP2E1 is often inferred from rodent CYP2E1 or truncated human CYP2E1 due to the lack of recombinant full-length human CYP2E1. This study developed a high-level bacterial expression of full-length human CYP2E1. Comparative studies of full-length and truncated human CYP2E1 in hydroxylation of chlorzoxazone and p-nitrophenol reveal that the N-terminal anchor of human CYP2E1 is critical for promoting interactions with NADPH-cytochrome P450 oxidoreductase and cytochrome-b5 and, hence, enzyme activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytochrome P-450 CYP2E1Escherichia coliHumansOxidation-ReductionRecombinant ProteinsChlorzoxazoneCytochromes b5Nitrophenols

Stichwörter der Autor:innen

Enzyme activityHeterologous expressionHuman CYP2E1Membrane anchorP450 reductasecyt b(5)

Substanzen

Cytochrome P-450 CYP2E1Recombinant ProteinsChlorzoxazoneCytochromes b5Nitrophenols4-nitrophenol

Autor:innen und Institutionen

  • Department of Pharmacology, The University of Michigan Medical School, Ann Arbor, Michigan.
  • Department of Pharmacology, The University of Michigan Medical School, Ann Arbor, Michigan. Electronic address: osawa@umich.edu.
  • Department of Pharmacology, The University of Michigan Medical School, Ann Arbor, Michigan. Electronic address: haom@umich.edu.

Förderung

  • NIGMS NIH HHS
  • University of Michigan
  • National Institute of General Medical Sciences
  • Biomedical Research Council
  • Medical School, University of Michigan
  • National Institutes of Health

Zitieren

APA

Sun, Y., Amunugama, P., Osawa, Y., & Zhang, H. (2026). High-level expression of full-length human CYP2E1 in Escherichia coli: Comparison of full-length human CYP2E1 to truncated counterpart shows enhanced association with redox partners. Drug Metabolism and Disposition, 54(7), 100344. https://doi.org/10.1016/j.dmd.2026.100344

Vancouver

Sun Y, Amunugama P, Osawa Y, Zhang H. High-level expression of full-length human CYP2E1 in Escherichia coli: Comparison of full-length human CYP2E1 to truncated counterpart shows enhanced association with redox partners. Drug Metabolism and Disposition. 2026;54(7):100344. doi:10.1016/j.dmd.2026.100344

BibTeX
@article{Sun2026,
  author = {Sun, Yudong and Amunugama, Praveen and Osawa, Yoichi and Zhang, Haoming},
  title = {High-level expression of full-length human CYP2E1 in Escherichia coli: Comparison of full-length human CYP2E1 to truncated counterpart shows enhanced association with redox partners},
  journal = {Drug Metabolism and Disposition},
  year = {2026},
  volume = {54},
  number = {7},
  pages = {100344},
  doi = {10.1016/j.dmd.2026.100344}
}
Kostenlos starten →